Clinical Trial Update: Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of the emtricitabine/tenofovir disoproxil fumarate/efavirenz combination in HIV-infected patients with tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: African Poverty Related Infection Oriented Research Initiative | Conditions: Tuberculosis, HIV Infections | Phase 2 | Status: UNKNOWN